If you’ve been researching medical weight loss options or diabetes management treatments, you may have come across Tirzepatide—a breakthrough medication that has shown promising results for patients. Whether you live in Novi, Northville, South Lyon, Brighton or Bloomfield. Understanding how this treatment works, what to expect, and key considerations before starting is essential.
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Unlike traditional GLP-1 medications, it targets two pathways, making it highly effective for managing blood sugar levels and promoting weight loss. It was originally designed for type 2 diabetes management, but it has gained attention for its significant weight loss benefits.
Learn more about PSI Medical Group and their approach to metabolic health.
However, Tirzepatide is not for everyone. If you have a history of thyroid cancer, pancreatitis, or severe gastrointestinal issues, you should discuss alternative treatments with a physician.
Before beginning treatment, here’s what you should know:
Schedule a consultation today to see if Tirzepatide is right for you.
According to a 2022 study published in The New England Journal of Medicine, patients on Tirzepatide lost 15% to 22% of their body weight over a 72-week period (Source). Additionally, the American Diabetes Association (ADA) has endorsed Tirzepatide as a promising diabetes treatment (Source).
If you're in Novi, Northville, South Lyon, Brighton or Bloomfield, and looking for expert-guided metabolic treatments, Dr. Robert C. Grafton, MD and the PSI Medical team can help. Contact us today to learn more about Tirzepatide and personalized wellness plans.
